title: Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke.
authors.affiliation: From French Alliance for Cardiovascular Trials, an F-CRIN Network, DHU FIRE, Paris, France (T.S., N.C.); INSERM U1148, Paris, France (T.S.); Department of Clinical Pharmacology, Unité de Recherche Clinique de l'Est Parisien (URC-EST), Assistance Publique-Hôpitaux de Paris, Paris, France (T.S.); Université Pierre et Marie Curie, Paris, France (T.S.); Université René Descartes, Paris, France (N.D.); and Assistance Publique-Hôpitaux de Paris, Department of Cardiology, Hopital Georges Pompidou, Paris, France (N.D.). tabassome.simon@aphp.fr.
authors.forename: Tabassome
authors.initials: T
authors.lastname: Simon
authors.affiliation: From French Alliance for Cardiovascular Trials, an F-CRIN Network, DHU FIRE, Paris, France (T.S., N.C.); INSERM U1148, Paris, France (T.S.); Department of Clinical Pharmacology, Unité de Recherche Clinique de l'Est Parisien (URC-EST), Assistance Publique-Hôpitaux de Paris, Paris, France (T.S.); Université Pierre et Marie Curie, Paris, France (T.S.); Université René Descartes, Paris, France (N.D.); and Assistance Publique-Hôpitaux de Paris, Department of Cardiology, Hopital Georges Pompidou, Paris, France (N.D.).
authors.forename: Nicolas
authors.initials: N
authors.lastname: Danchin
mesh_terms: D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors; D020521:Stroke; D013988:Ticlopidine / Q000031:analogs & derivatives; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine
keywords: Editorials; outcome assessment (health care); pharmacogenetics; platelet aggregation inhibitors; stroke; thrombosis